MREO (Mereo BioPharma Group) EV-to-Revenue : (As of May. 23, 2025)

Mereo BioPharma Group EV-to-Revenue Chart

Mereo BioPharma Group Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-Revenue		Get a 7-Day Free Trial					-	1.72	-	27.91	-

Mereo BioPharma Group Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															41.53	448.45	553.90	-	-

Competitive Comparison of Mereo BioPharma Group's EV-to-Revenue

For the Biotechnology subindustry, Mereo BioPharma Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mereo BioPharma Group's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's EV-to-Revenue falls into.

Mereo BioPharma Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mereo BioPharma Group's EV-to-Revenue for today is calculated as:

Mereo BioPharma Group's current Enterprise Value is $300.79 Mil.
Mereo BioPharma Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mereo BioPharma Group  (NAS:MREO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mereo BioPharma Group's PS Ratiofor today is calculated as:

Mereo BioPharma Group's share price for today is $2.24.
Mereo BioPharma Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mereo BioPharma Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group Business Description